Literature DB >> 6200929

Characterization of exogenous type D retrovirus from a fibroma of a macaque with simian AIDS and fibromatosis.

K Stromberg, R E Benveniste, L O Arthur, H Rabin, W E Giddens, H D Ochs, W R Morton, C C Tsai.   

Abstract

A novel type D retrovirus was isolated by cocultivation of explants of fibromatous tissue from a rhesus monkey (Macaca mulatta) with immunodeficiency and retroperitoneal fibromatosis. This type D virus, isolated from a macaque with simian acquired immunodeficiency syndrome (SAIDS-D/Washington), is exogenous and is partially related to the Mason-Pfizer and the langur monkey type D viruses. The SAiDS-D virus can be distinguished from all other primate retroviruses by antigenicity and molecular hybridization. Nucleic acid hybridization studies reveal that the origin of the SAIDS-D isolate may reside in Old World monkey (subfamily Colobinae) cellular DNA.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6200929     DOI： 10.1126/science.6200929

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  37 in total

1.  Virus load and sequence variation in simian retrovirus type 2 infection.

Authors:  L L Rosenblum; R A Weiss; M O McClure
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Protection of macaques against infection with simian type D retrovirus (SRV-1) by immunization with recombinant vaccinia virus expressing the envelope glycoproteins of either SRV-1 or Mason-Pfizer monkey virus (SRV-3).

Authors:  B A Brody; E Hunter; J D Kluge; R Lasarow; M Gardner; P A Marx
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

3.  Lessons in nonhuman primate models for AIDS vaccine research: from minefields to milestones.

Authors:  Jeffrey D Lifson; Nancy L Haigwood
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

4.  Induction of simian acquired immune deficiency syndrome (SAIDS) with a molecular clone of a type D SAIDS retrovirus.

Authors:  G Heidecker; N W Lerche; L J Lowenstine; A A Lackner; K G Osborn; M B Gardner; P A Marx
Journal:  J Virol       Date:  1987-10       Impact factor: 5.103

5.  Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccine.

Authors:  P A Marx; N C Pedersen; N W Lerche; K G Osborn; L J Lowenstine; A A Lackner; D H Maul; H S Kwang; J D Kluge; C P Zaiss
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

6.  Simian retrovirus D serogroup 1 has a broad cellular tropism for lymphoid and nonlymphoid cells.

Authors:  D H Maul; C P Zaiss; M R MacKenzie; S M Shiigi; P A Marx; M B Gardner
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

7.  Retrovirus D/New England and its relation to Mason-Pfizer monkey virus.

Authors:  R C Desrosiers; M D Daniel; C V Butler; D K Schmidt; N L Letvin; R D Hunt; N W King; C S Barker; E Hunter
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

8.  Protection of macaques against simian AIDS by immunization with a recombinant vaccinia virus expressing the envelope glycoproteins of simian type D retrovirus.

Authors:  S L Hu; J M Zarling; J Chinn; B M Travis; P A Moran; J Sias; L Kuller; W R Morton; G Heidecker; R E Benveniste
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Toxicity and efficacy of 2',3'-dideoxycytidine in clinical trials of pigtailed macaques infected with simian retrovirus type 2.

Authors:  C C Tsai; K E Follis; M Yarnall; G A Blakley
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

10.  Subcutaneous fibromatosis associated with an acquired immune deficiency syndrome in pig-tailed macaques.

Authors:  C C Tsai; T F Warner; H Uno; W E Giddens; H D Ochs
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.